Article
Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.
British journal of clinical pharmacology - 1 Oct 2006
Zhong Shilong, Huang Min, Yang Xiuyan, Liang Liuqin, Wang Yixi, Romkes Marjorie, Duan Wei, Chan Eli, Zhou Shu-Feng
Abstract excerpt
AIMS: Cyclophosphamide (CTX) is an established treatment of severe systemic lupus erythematosus (SLE). Cytotoxic CTX metabolites are mainly detoxified by multiple glutathione S-transferases (GSTs). However, data are lacking on the relationship between the short-term side-effects of CTX therapy and GST genotypes. In the present study, the effects of common GSTM1, GSTT1, and GSTP1 genetic mutations on the severity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
